StockGuru News: The Immune Response Corporation (OTCBB: IMNR)
The Immune Response Corporation (OTCBB: IMNR) The Immune Response Corporation (OTCBB: IMNR) Receives $9.9 Million from Exercise of First Tranche of Warrants Raising Aggregate $17.9 Million from 2006 Financing Funding Will Support Continuation of Phase II Clinical Trials In Multiple Sclerosis and HIV CARLSBAD, Calif.–Aug. 10, 2006–The Immune Response Corporation (OTCBB: IMNR), an immuno-pharmaceutical company developing products to treat autoimmune and infectious diseases, announced it has raised $9.9 million in gross proceeds from investors exercising 495,552,100 warrants from the first tranche warrants that were issued in the Company’s March 2006 private placement financing. The total gross proceeds include an investment…